A comparison of ad hoc methods to account for non-cancer AIDS and deaths as competing risks when estimating the effect of HAART on incident cancer AIDS among HIV-infected men
- 2 November 2009
- journal article
- research article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 63 (4) , 459-467
- https://doi.org/10.1016/j.jclinepi.2009.08.003
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Survival Analysis Using SAS: A Practical Guide. Second Edition By Paul D. AllisonAmerican Journal of Epidemiology, 2011
- Effect of Highly Active Antiretroviral Therapy on Incident AIDS Using Calendar Period as an Instrumental VariableAmerican Journal of Epidemiology, 2009
- Choice and Interpretation of Statistical Tests Used When Competing Risks Are PresentJournal of Clinical Oncology, 2008
- Estimation of HIV Incidence in the United StatesJAMA, 2008
- Effect of HAART on Incident Cancer and Noncancer AIDS Events Among Male HIV SeroconvertersJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- Tutorial in biostatistics: competing risks and multi‐state modelsStatistics in Medicine, 2006
- Determinants of survival following HIV-1 seroconversion after the introduction of HAARTThe Lancet, 2003
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- THE MULTICENTER AIDS COHORT STUDY: RATIONALE, ORGANIZATION, AND SELECTED CHARACTERISTICS OF THE PARTICIPANTSAmerican Journal of Epidemiology, 1987